How liver disease affects a new medication in the body

Researchers studied how mavorixafor, an experimental medication, behaved differently in people with liver disease versus people with normal liver function. The trial examined whether having mild, moderate, or severe liver disease changed how the body processes and tolerates this single dose of the medication. This information helps doctors understand whether the dose needs to be adjusted for patients with liver problems.

When the liver doesn't work as well, it can change how medications move through your body and how your body breaks them down. Researchers needed to understand these differences so they could safely use this medication in people living with liver disease.